Ensign Group/$ENSG

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Ensign Group

Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.

Ticker

$ENSG
Primary listing

Industry

Health Care Providers & Services

Employees

39,300

ISIN

US29358P1012

Ensign Group Metrics

BasicAdvanced
$8.3B
27.50
$5.30
0.92
$0.25
0.17%

What the Analysts think about Ensign Group

Analyst ratings (Buy, Hold, Sell) for Ensign Group stock.

Bulls say / Bears say

Ensign Group reported a 14% year-over-year revenue increase in 2024, reaching $4.3 billion, indicating strong market demand and effective operational execution. (panabee.com)
The company expanded into new states, including Alabama and Tennessee, diversifying its geographic footprint and reducing reliance on existing markets. (panabee.com)
Ensign Group raised its 2025 earnings guidance to between $6.22 to $6.38 per diluted share, reflecting confidence in continued growth and operational momentum. (santelog.com)
Despite overall revenue growth, skilled mix by revenue decreased by 1.6% to 48.6% in 2024, suggesting a shift towards lower-reimbursement payor sources. (panabee.com)
The company faces ongoing government scrutiny, including a DOJ Civil Investigative Demand in January 2024, investigating potential False Claims Act violations. (panabee.com)
Changes in CMS's Five-Star Quality Rating System create unpredictability in quality ratings, which could negatively impact patient referrals and market perception. (panabee.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.

Ensign Group Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Ensign Group Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ENSG

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jul31
Ensign Group
Dividend·Payment
$0.0625Per share
FAQs